Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril.

P. Madeddu, M. Oppes, S. Rubattu, F. Bandiera, P. Dessi'-Fulgheri, N. Glorioso, A. Soro, M. Chiara-Troffa, A. Rappelli

Research output: Contribution to journalArticle

Abstract

The antihypertensive efficacy of ACE inhibitors depends in theory from the blockade of the angiotensin II formation but also from the inhibition of kinin breakdown. To test whether a blunted activity of the kallikrein-kinin system might account for the failure of ACE inhibitors in lowering BP in patients in whom the renin-angiotensin system is not enhanced, thirty-one essential hypertensives with normal or low PRA were evaluated before and after a single oral dose (50 mg) of captopril. A significant fall both in systolic and diastolic blood pressure (BP) was obtained in the subgroup of patients who were classified as "normal kallikrein hypertensives" according to whether their pretreatment urinary kallikrein excretion was within the normal range, while no significant change in BP was observed in "low kallikrein hypertensives". Furthermore the mean percentage fall in mean BP, throughout the 2 hours following captopril administration, was significantly related to the basal value of urinary kallikrein excretion (r = 0.47, p less than 0.05) in the entire group of patients. Our results suggest that a blunted activity of the kallikrein system might be responsible for failure of captopril in lowering BP in patients in whom the renin-angiotensin system is not pathogenetically implicated.

Original languageEnglish
Pages (from-to)321-328
Number of pages8
JournalAgents and Actions Supplements
Volume22
Publication statusPublished - 1987

Fingerprint

Tissue Kallikreins
Captopril
Blood Pressure
Kallikreins
Renin-Angiotensin System
Angiotensin-Converting Enzyme Inhibitors
Kallikrein-Kinin System
Kinins
Angiotensin II
Antihypertensive Agents
Reference Values

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril. / Madeddu, P.; Oppes, M.; Rubattu, S.; Bandiera, F.; Dessi'-Fulgheri, P.; Glorioso, N.; Soro, A.; Chiara-Troffa, M.; Rappelli, A.

In: Agents and Actions Supplements, Vol. 22, 1987, p. 321-328.

Research output: Contribution to journalArticle

Madeddu, P, Oppes, M, Rubattu, S, Bandiera, F, Dessi'-Fulgheri, P, Glorioso, N, Soro, A, Chiara-Troffa, M & Rappelli, A 1987, 'Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril.', Agents and Actions Supplements, vol. 22, pp. 321-328.
Madeddu, P. ; Oppes, M. ; Rubattu, S. ; Bandiera, F. ; Dessi'-Fulgheri, P. ; Glorioso, N. ; Soro, A. ; Chiara-Troffa, M. ; Rappelli, A. / Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril. In: Agents and Actions Supplements. 1987 ; Vol. 22. pp. 321-328.
@article{fc598a33208942eb9812f92bedef8167,
title = "Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril.",
abstract = "The antihypertensive efficacy of ACE inhibitors depends in theory from the blockade of the angiotensin II formation but also from the inhibition of kinin breakdown. To test whether a blunted activity of the kallikrein-kinin system might account for the failure of ACE inhibitors in lowering BP in patients in whom the renin-angiotensin system is not enhanced, thirty-one essential hypertensives with normal or low PRA were evaluated before and after a single oral dose (50 mg) of captopril. A significant fall both in systolic and diastolic blood pressure (BP) was obtained in the subgroup of patients who were classified as {"}normal kallikrein hypertensives{"} according to whether their pretreatment urinary kallikrein excretion was within the normal range, while no significant change in BP was observed in {"}low kallikrein hypertensives{"}. Furthermore the mean percentage fall in mean BP, throughout the 2 hours following captopril administration, was significantly related to the basal value of urinary kallikrein excretion (r = 0.47, p less than 0.05) in the entire group of patients. Our results suggest that a blunted activity of the kallikrein system might be responsible for failure of captopril in lowering BP in patients in whom the renin-angiotensin system is not pathogenetically implicated.",
author = "P. Madeddu and M. Oppes and S. Rubattu and F. Bandiera and P. Dessi'-Fulgheri and N. Glorioso and A. Soro and M. Chiara-Troffa and A. Rappelli",
year = "1987",
language = "English",
volume = "22",
pages = "321--328",
journal = "Agents and Actions Supplements",
issn = "0379-0363",
publisher = "Birkhauser Verlag Basel",

}

TY - JOUR

T1 - Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril.

AU - Madeddu, P.

AU - Oppes, M.

AU - Rubattu, S.

AU - Bandiera, F.

AU - Dessi'-Fulgheri, P.

AU - Glorioso, N.

AU - Soro, A.

AU - Chiara-Troffa, M.

AU - Rappelli, A.

PY - 1987

Y1 - 1987

N2 - The antihypertensive efficacy of ACE inhibitors depends in theory from the blockade of the angiotensin II formation but also from the inhibition of kinin breakdown. To test whether a blunted activity of the kallikrein-kinin system might account for the failure of ACE inhibitors in lowering BP in patients in whom the renin-angiotensin system is not enhanced, thirty-one essential hypertensives with normal or low PRA were evaluated before and after a single oral dose (50 mg) of captopril. A significant fall both in systolic and diastolic blood pressure (BP) was obtained in the subgroup of patients who were classified as "normal kallikrein hypertensives" according to whether their pretreatment urinary kallikrein excretion was within the normal range, while no significant change in BP was observed in "low kallikrein hypertensives". Furthermore the mean percentage fall in mean BP, throughout the 2 hours following captopril administration, was significantly related to the basal value of urinary kallikrein excretion (r = 0.47, p less than 0.05) in the entire group of patients. Our results suggest that a blunted activity of the kallikrein system might be responsible for failure of captopril in lowering BP in patients in whom the renin-angiotensin system is not pathogenetically implicated.

AB - The antihypertensive efficacy of ACE inhibitors depends in theory from the blockade of the angiotensin II formation but also from the inhibition of kinin breakdown. To test whether a blunted activity of the kallikrein-kinin system might account for the failure of ACE inhibitors in lowering BP in patients in whom the renin-angiotensin system is not enhanced, thirty-one essential hypertensives with normal or low PRA were evaluated before and after a single oral dose (50 mg) of captopril. A significant fall both in systolic and diastolic blood pressure (BP) was obtained in the subgroup of patients who were classified as "normal kallikrein hypertensives" according to whether their pretreatment urinary kallikrein excretion was within the normal range, while no significant change in BP was observed in "low kallikrein hypertensives". Furthermore the mean percentage fall in mean BP, throughout the 2 hours following captopril administration, was significantly related to the basal value of urinary kallikrein excretion (r = 0.47, p less than 0.05) in the entire group of patients. Our results suggest that a blunted activity of the kallikrein system might be responsible for failure of captopril in lowering BP in patients in whom the renin-angiotensin system is not pathogenetically implicated.

UR - http://www.scopus.com/inward/record.url?scp=0023515290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023515290&partnerID=8YFLogxK

M3 - Article

C2 - 3324715

AN - SCOPUS:0023515290

VL - 22

SP - 321

EP - 328

JO - Agents and Actions Supplements

JF - Agents and Actions Supplements

SN - 0379-0363

ER -